Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)

ASE:HPIC Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	31	31	23	23	28	36
Market Cap Growth	29.37%	34.69%	2.08%	-18.64%	-22.16%	56.61%
Enterprise Value	25	27	19	18	24	32
Last Close Price	3.26	3.12	2.15	1.97	2.23	2.69
PE Ratio	15.28	13.58	7.53	9.80	7.94	9.89
PS Ratio	1.90	1.83	1.39	1.44	1.64	2.17
PB Ratio	0.99	1.01	0.76	0.78	0.95	1.28
P/TBV Ratio	0.99	1.01	0.76	0.78	0.95	1.28
P/FCF Ratio	8.03	9.90	14.67	9.34	12.54	9.12
P/OCF Ratio	6.02	8.76	7.10	8.20	9.01	6.51
EV/Sales Ratio	1.53	1.57	1.13	1.14	1.38	1.95
EV/EBITDA Ratio	6.52	6.45	3.94	4.60	4.47	6.08
EV/EBIT Ratio	9.58	9.12	5.12	6.36	5.60	7.32
EV/FCF Ratio	6.48	8.48	11.90	7.39	10.53	8.20
Debt / Equity Ratio	0.14	0.11	0.12	0.07	0.04	0.07
Debt / EBITDA Ratio	1.13	0.84	0.80	0.49	0.23	0.39
Debt / FCF Ratio	1.12	1.10	2.41	0.79	0.53	0.53
Net Debt / Equity Ratio	-0.19	-0.20	-0.17	-0.18	-0.18	-0.20
Net Debt / EBITDA Ratio	-1.56	-1.46	-1.09	-1.35	-1.03	-1.06
Net Debt / FCF Ratio	-1.55	-1.92	-3.29	-2.18	-2.43	-1.43
Asset Turnover	0.42	0.46	0.47	0.46	0.51	0.51
Inventory Turnover	1.82	2.29	2.09	1.64	1.75	1.79
Quick Ratio	4.82	5.51	5.89	4.69	3.47	3.79
Current Ratio	5.77	6.32	7.08	5.87	4.37	4.74
Return on Equity (ROE)	6.49%	7.46%	10.27%	7.93%	12.26%	13.32%
Return on Assets (ROA)	4.22%	4.91%	6.42%	5.19%	7.84%	8.42%
Return on Invested Capital (ROIC)	8.51%	9.57%	12.99%	10.06%	15.43%	16.40%
Return on Capital Employed (ROCE)	7.60%	8.80%	10.80%	9.20%	14.30%	15.20%
Earnings Yield	6.54%	7.36%	13.27%	10.21%	12.59%	10.12%
FCF Yield	12.45%	10.10%	6.82%	10.71%	7.98%	10.96%
Dividend Yield	5.97%	6.09%	10.24%	8.38%	11.20%	9.30%
Payout Ratio	103.13%	90.55%	50.73%	102.03%	67.31%	52.17%
Total Shareholder Return	2.79%	6.09%	10.24%	8.38%	11.20%	9.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.